Preserve Access to Affordable Generics and Biosimilars Act

United States117e CongrèsS-1428Senate
Mis à jour : 9 déc. 2021

Résumé

Aucun résumé n’est disponible.

Textes du projet de loi

Versions disponibles
Consulter le texte officiel

2 versions disponibles

Tous les dossiers disponibles sont affichés.

Chronologie

Dernière mesure du projet de loi complémentaire

HR-2891: Preserve Access to Affordable Generics and Biosimilars Act

Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 28 - 13.

  1. Read twice and referred to the Committee on the Judiciary.

    Senate

  2. Committee on the Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably.

    Senate

  3. Placed on Senate Legislative Calendar under General Orders. Calendar No. 180.

    Senate

  4. Committee on the Judiciary. Reported by Senator Durbin with an amendment in the nature of a substitute. Without written report.

    Senate